Singlera Genomics Funding: $233M Raised, Series B (2020)
Singlera Genomics is based in San Diego. It has raised $233M in total funding. Latest round: Series B.
Singlera Genomics funding overview
Singlera Genomics is based in San Diego. Singlera Genomics has raised $233M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2020. The round record for Singlera Genomics runs through 2020; nothing later has been disclosed. Investors on record include CICC Kai Tak Innovative Biomedicine Fund, Detong Capital, Furong Investment, Huamei International, Linden Asset Group, Wuxi Capital and 5 others. 11 distinct backers are named across the disclosed rounds.
Singlera Genomics at a glance
Total raised
$233M
Latest round
Series B
Latest round date
December 2020
Headquarters
San Diego
Notable investors
CICC Kai Tak Innovative Biomedicine Fund, Detong Capital, Furong Investment, Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, Shanghai Free Trade Zone Fund
Frequently asked about Singlera Genomics funding
How much has Singlera Genomics raised?
Singlera Genomics has raised $233M in total disclosed funding across the rounds on record.
Who has invested in Singlera Genomics?
CICC Kai Tak Innovative Biomedicine Fund, Detong Capital, Furong Investment, Huamei International, Linden Asset Group, Wuxi Capital are named among the investors backing Singlera Genomics.
What was the latest Singlera Genomics funding round?
The most recent disclosed round is a Series B, announced in December 2020.
Where is Singlera Genomics based?
Singlera Genomics is based in San Diego.
When did Singlera Genomics last raise?
The last disclosed Singlera Genomics round closed in December 2020 at Series B.
Every Singlera Genomics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.
